| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Forbion Capital Fund III Cooperatief U.A. last filed a Form 4 in July 2018, as 10% Owner at REPL.
At the last filing, the largest reported position was 4,721,449 shares of REPL. Net of sales, the REPL filings show accumulation of 133,333 shares.
Forbion Capital Fund III Cooperatief U.A. has 1 Form 4 filing on record in July 2018, as 10% Owner at Replimune Group (REPL), 2018.
The 4 reported transactions were 3 conversions and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $2.0M and no sales.
The only open-market purchase was 133,333 shares of REPL at an average $15.00 on July 24, 2018, about $2.0M.
Shares as reported in the last Form 4 for each company; the most recent is from July 2018. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 24, 2018 | REPL Replimune Group, Inc. | 10% Owner | Buy | 133,333 | $15.00 | $1,999,995.00 | +2.9% |